Provider QP115-20 Medtronic Continuous Glucose Monitoring Device and Insulin Pump Systems Now Available Through the Pharmacy Benefit Read More
Provider QP116-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Evrenzo® Read More
Provider QP107-20 Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective January 1, 2021 Read More
Provider QP108-20 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) with Quantity Limit (QL) Criteria: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and Combinations Read More
